• Home
  • Ongoing Clinical Studies

Ongoing Clinical Studies

Filter Clinical Studies by:

Name

Physician(s)

all-types

Name

A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases ›

Physician(s)

Frank A. Vicini, MD, FACR, FASTRO
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR, FABS, FASTRO

Name

Evaluation of the CytoRADxTM System as a Biodosimeter with Human Subjects Receiving Radiation Therapy ›

Physician(s)

Christopher T. Chen, MD, FACRO
Constantine A. Mantz, MD

Name

Radiotherapy Assessments During Intervention ANd Treatment ›

Physician(s)

Christopher T. Chen, MD, FACRO
Constantine A. Mantz, MD
John E. Sylvester, MD

Blood

Name

A Disease Registry for Patients with Chronic Lymphocytic Leukemia ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

A Prospective Observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta® (pegfilgrastim) Onpro® kit or Other Physician Choice Options for Prophylaxis ›

Physician(s)

Troy H. Guthrie, Jr., MD

Name

Prospective, Longitudinal, Non-Interventional Study Of Disease Burden And Treatment Of Patients With Low-Risk Myelofibrosis (MF) Or High-Risk Essential Thrombocythemia (ET) Or ET Patients Receiving ET-Directed Therapy  ›

Physician(s)

Troy H. Guthrie, Jr., MD

Brain-Cancer

Name

A Randomized, Phase III Trial Of Memantine and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Patients With Brain Metastases ›

Physician(s)

Frank A. Vicini, MD, FACR, FASTRO
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR, FABS, FASTRO

Breast-Cancer

Name

A Phase IIR/III Trial of Standard of Care with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer ›

Physician(s)

Frank A. Vicini, MD, FACR, FASTRO
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR, FABS, FASTRO

Name

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chest Wall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy ›

Physician(s)

Frank A. Vicini, MD, FACR, FASTRO
John Vito Antonucci, MD
Michael I. Ghilezan, MD, PhD
Alvaro A. Martinez, MD, FACR, FABS, FASTRO

Name

MROQC ›

Physician(s)

Larry L. Kestin, MD, FACR

Back
To top